Scopus BioPharma Inc. filed its 10-K on Apr 14, 2023 for the period ending Dec 31, 2022. In this report its auditor, Citrin Cooperman & Company, LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0011 USD | -47.62% | 0.00% | -97.45% |
1st Jan change | Capi. | |
---|---|---|
-97.45% | 46.29K | |
+2.97% | 108B | |
+10.21% | 104B | |
+2.42% | 22.33B | |
-12.77% | 22.19B | |
-7.05% | 18.69B | |
-37.64% | 17.74B | |
-6.50% | 17.64B | |
+6.00% | 14.05B | |
+37.20% | 12.51B |
- Stock Market
- Equities
- SCPS Stock
- News Scopus BioPharma Inc.
- Scopus BioPharma Inc. Auditor Raises 'Going Concern' Doubt